Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron
- 12 September 1997
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 61 (16) , PL249-PL254
- https://doi.org/10.1016/s0024-3205(97)00745-5
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mecamylamine-precipitated nicotine-withdrawal aversion in ratsEuropean Journal of Pharmacology, 1996
- Effects of nicotine withdrawal on central dopaminergic systemsPharmacology Biochemistry and Behavior, 1996
- The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the ratPsychopharmacology, 1994
- Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawalPsychopharmacology, 1991
- Symptoms of Tobacco WithdrawalArchives of General Psychiatry, 1991
- Effects of the 5-HT3 antagonist GR38032F (ondansetron) on benzodiazepine withdrawal in ratsEuropean Journal of Pharmacology, 1990
- The use of place conditioning in studying the neuropharmacology of drug reinforcementBrain Research Bulletin, 1989
- Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the ratBrain Research, 1987
- Effects of nicotine on body weight and food consumption in female ratsPsychopharmacology, 1986
- Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioningPsychopharmacology, 1985